Bone marrow donation: Facts, myths, and the process

Bone marrow donation links healthy volunteers with patients who need healthy blood-forming stem cells to rebuild their immune and blood systems. These transplants are used for conditions such as leukemia, lymphoma, aplastic anemia, certain immune deficiencies, and some inherited blood diseases. Because accurate information matters, this article focuses on clarifying common myths, outlining eligibility, explaining how collection works, and describing realistic risks and recovery timelines.

Key facts, myths, and how the process works

Several myths persist. Donation is not a procedure on the spinal cord; stem cells are collected from blood (most often) or from the pelvic bone marrow, far from the spine. Most donations today use peripheral blood stem cell (PBSC) collection, which is non-surgical. When a surgical harvest is needed, it is done under anesthesia, and donors typically go home the same day or the next. Another myth is that donors “lose” their marrow permanently; in reality, the body replenishes donated cells, usually within weeks. Matching is based on human leukocyte antigen (HLA) markers, which means a close relative or an unrelated person with similar HLA can be a match. Donors are screened carefully, supported throughout the process, and followed up afterward to ensure recovery.

What is bone marrow donation?

Bone marrow donation provides hematopoietic (blood-forming) stem cells that can mature into red cells, white cells, and platelets. In an allogeneic transplant, these cells come from a compatible donor rather than the patient. After high-dose therapy removes diseased or dysfunctional marrow, the donated cells repopulate the recipient’s marrow, restoring blood and immune function. Donors may be related (often a sibling) or unrelated, identified through registries. The donation itself is a one-time procedure for a specific patient, scheduled and tailored to clinical need and the donor’s health status.

Who can donate? Eligibility and screening

Eligibility varies by registry and country, but several themes are common. Adult donors are generally required; many registries enroll people between 18 and 35 because younger donors are associated with better outcomes, though some accept new registrants up to around 40–60. Health status is key: a history of certain cancers, significant heart or lung disease, uncontrolled autoimmune conditions, active infections, or some blood disorders can be disqualifying. Temporary deferrals are common for pregnancy, recent tattoos or piercings, and some travel-related exposures. Body weight and height may be considered for safety.

Screening typically starts with an online or paper health questionnaire and a cheek swab for HLA typing. If you match a patient, confirmatory testing follows: blood tests, a physical exam, infectious disease screening, and sometimes additional imaging or cardiac checks. Final clearance ensures the procedure is safe for the donor and suitable for the recipient’s treatment plan. Policies differ globally, so local services in your area or national registries provide the most accurate criteria.

Types of donation: peripheral blood stem cell (PBSC) vs. marrow harvest

PBSC donation is the most common method. Donors receive daily injections of a naturally occurring growth factor (such as filgrastim) for about four to five days to coax stem cells from bone marrow into the bloodstream. On collection day, blood is drawn from one arm, passes through an apheresis machine that separates stem cells, and returns through the other arm. The session generally lasts four to eight hours and may be repeated the next day if needed. Most donors experience temporary bone or muscle aches, headaches, and fatigue from the medication; symptoms usually resolve within a few days.

Marrow harvest is a short surgical procedure under anesthesia, typically drawing liquid marrow from the back of the pelvic bones with special needles. No incisions are made—just puncture sites. The procedure often takes one to two hours. Soreness in the hips and lower back, bruising at the sites, and fatigue are common afterward. Many donors resume light activities within a few days, with full recovery often occurring within one to two weeks, though timing varies.

Risks, side effects, and expected recovery

For PBSC donation, the temporary side effects from the growth factor—achiness, headache, and fatigue—are most common. During apheresis, some donors feel tingling from low calcium levels caused by the machine’s anticoagulant; this is usually managed quickly with calcium supplements. Rare complications include allergic reactions to medications or, very rarely, spleen-related issues. Blood counts typically return to pre-donation levels within days to weeks.

For marrow harvest, donors experience post-anesthesia grogginess, hip or back soreness, and mild bruising. Rare risks include infection at puncture sites, significant bleeding, or reactions to anesthesia. Hospitals monitor donors closely, and most issues, when they occur, are manageable. Long-term studies have not shown increased risk of blood disorders in donors. Regardless of method, donors receive instructions on hydration, pain control with common analgesics as appropriate, and activity pacing. A follow-up plan checks in on recovery and addresses any concerns promptly.

In summary, donation today is designed to be safe, well-supported, and centered on donor well-being. Understanding the difference between PBSC collection and marrow harvest, knowing how matching and screening work, and having a realistic view of short-term side effects can make the process clearer. While experiences vary, most donors report temporary discomforts and a return to normal routines within days to a couple of weeks.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.